Literature DB >> 16839220

Risk of endometrial cancer mortality by ever-use of sex hormones and other factors in Japan.

Mmh Khan1, Mitsuru Mori, Fumio Sakauchi, Khandoker Aklimunnessa, Tatsuhiko Kubo, Yoshihisa Fujino, Sadao Suzuki, Shinkan Tokudome, Akiko Tamakosh.   

Abstract

OBJECTIVES: To examine associations of ever-use of sex hormones (EUSH) and other factors with endometrial cancer (EC) mortality through a nation-wide Japan Collaborative Cohort Study.
METHODS: A total of 63,541 women aged 40-79 years, enrolled in 1988-90 from 45 municipalities of Japan, were followed until 2003 to record their vital status. Using baseline data, the Cox proportional hazard model (age adjusted and multivariate) was used to estimate the hazard ratio (HR) and 95% confidence interval (CI) for EC mortality by selected factors, including EUSH. Bivariate analysis was also conducted to establish associations between EUSH and other factors.
RESULTS: The mortality rate from EC was 2.6 per 100,000 person-years during the mean follow-up period of 13.3 years. Prevalence rate of EUSH was 5.2%. Significantly increased risk of EC mortality was found for EUSH with both age adjusted (HR=6.43, 95%CI=2.10-19.67) and multivariate (HR=5.33; 95%CI=1.51-18.82) analyses. Bivariate analysis indicated that history of diabetes mellitus, smoking, drinking, and age at first delivery were positively associated with EUSH, whereas age, number of delivery, number of pregnancy, and age at menarche demonstrated inverse links.
CONCLUSIONS: Our results imply that EUSH may increase the risk of EC mortality among Japanese women. However, further studies with more deaths are needed to validate the results.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16839220

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Impact of Type 2 Diabetes Mellitus on Endometrial Cancer Survival: A Prospective Database Analysis.

Authors:  Kelechi Njoku; Heather J Agnew; Emma J Crosbie
Journal:  Front Oncol       Date:  2022-05-05       Impact factor: 5.738

2.  The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients.

Authors:  Chantal C Orgéas; Per Hall; Sara Wedrén; Paul W Dickman; Kamila Czene
Journal:  Eur J Cancer       Date:  2009-06-01       Impact factor: 9.162

3.  Association between dietary fiber and endometrial cancer: a dose-response meta-analysis.

Authors:  Elisa V Bandera; Lawrence H Kushi; Dirk F Moore; Dina M Gifkins; Marjorie L McCullough
Journal:  Am J Clin Nutr       Date:  2007-12       Impact factor: 7.045

4.  Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial.

Authors:  Ashley S Felix; D Scott McMeekin; David Mutch; Joan L Walker; William T Creasman; David E Cohn; Shamshad Ali; Richard G Moore; Levi S Downs; Olga B Ioffe; Kay J Park; Mark E Sherman; Louise A Brinton
Journal:  Gynecol Oncol       Date:  2015-09-01       Impact factor: 5.482

Review 5.  Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies.

Authors:  Caiyun Liao; Dongyu Zhang; Chemtai Mungo; D Andrew Tompkins; Amer M Zeidan
Journal:  Gynecol Oncol       Date:  2014-07-27       Impact factor: 5.482

6.  Age at menarche and endometrial cancer risk: a dose-response meta-analysis of prospective studies.

Authors:  Ting-Ting Gong; Yong-Lai Wang; Xiao-Xin Ma
Journal:  Sci Rep       Date:  2015-09-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.